SCHEMBL7346967

SCHEMBL7346967

COc1ccc([C@@H]2Sc3c(ccc4ccccc34)N(CCN(C)C)C(=O)[C@@H]2OC(C)=O)cc1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CACNA1S Q13698 12/20 0.72
▸ CYP3A4 P08684 3/20 0.72
▸ TSHR P16473 2/20 0.72
▸ ABCB11 O95342 2/20 0.72
▸ LMNA P02545 2/20 0.72
▸ KCNH2 Q12809 2/20 0.72
▸ SLC22A1 O15245 1/20 0.72
▸ CACNA1F O60840 1/20 0.72
▸ ABCB1 P08183 1/20 0.72
▸ HRH2 P25021 1/20 0.72
▸ ADRA1A P35348 1/20 0.72
▸ SCN1A P35498 1/20 0.72
▸ SCN4A P35499 1/20 0.72
▸ HTT P42858 1/20 0.72
▸ SCN7A Q01118 1/20 0.72
▸ CACNA1D Q01668 1/20 0.72
▸ PLAUR Q03405 1/20 0.72
▸ CACNA1C Q13936 1/20 0.72
▸ SCN5A Q14524 1/20 0.72
▸ SCN9A Q15858 1/20 0.72

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7413659 1.00 CACNA1S (0.72) CACNA1SCYP3A4TSHRABCB11LMNA
SCHEMBL7346971 1.00 CACNA1S (0.72) CACNA1SCYP3A4TSHRABCB11LMNA
Hydrochloric Acid SCHEMBL7412129 0.99 CYP3A4 (0.73) CACNA1SCYP3A4TSHRABCB11LMNA
Hydrochloric Acid SCHEMBL30357977 0.99 CYP3A4 (0.73) CACNA1SCYP3A4TSHRABCB11LMNA
Hydrochloric Acid SCHEMBL7410428 0.99 CYP3A4 (0.73) CACNA1SCYP3A4TSHRABCB11LMNA
SCHEMBL7412151 0.95 CACNA1S (0.65) CACNA1SCYP3A4TSHRABCB11LMNA
Hydrochloric Acid SCHEMBL7407925 0.94 CYP3A4 (0.66) CACNA1SCYP3A4TSHRABCB11LMNA
SCHEMBL7409376 0.92 CACNA1S (0.61) CACNA1SCYP3A4TSHRABCB11LMNA
SCHEMBL7410661 0.92 CACNA1S (0.61) CACNA1SCYP3A4TSHRABCB11LMNA
SCHEMBL10718635 0.92 CACNA1S (0.61) CACNA1SCYP3A4TSHRABCB11LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4808580-A Naphtho[1,2-b][1,4]thiazepin-4(5H)-ones and use thereof in treatment of ischemia and blood pressure lowering HOFFMANN-LA ROCHE INC. (US) 1989-02-28 — — US claimed
EP-0234561-A2 2,3-Dihydro-2-phenyl-5-aminoalkyl-naphtho [1,2-b]-1,4-thiazepin-4(5H)-one derivatives F. HOFFMANN-LA ROCHE AG (CH) 1987-09-02 — — EP claimed
US-4652561-A HYPOTENSIVE AGENTS, ANTIISCHEMIC AGENTS HOFFMANN-LA ROCHE INC. (US) 1987-03-24 — — US claimed
EP-0662322-B1 Pharmaceutical composition for controlled release DOW CHEMICAL CO (US) 2002-03-27 — — EP disclosed
EP-0662322-A2 Pharmaceutical composition for controlled release F. HOFFMANN-LA ROCHE AG (CH) 1995-07-12 — — EP disclosed
US-5393765-A Includes hydroxypropyl methylcellulose; solubility; viscosity HOFFMANN-LA ROCHE INC. (US) 1995-02-28 — — US disclosed
US-5008411-A Glycidic acid ester and process of preparation HOFFMANN-LA ROCHE INC. (US) 1991-04-16 — — US disclosed
US-4912102-A Calcium antagonist activity HOFFMANN-LA ROCHE INC. (US) 1990-03-27 — — US disclosed
EP-0343474-A2 Process for the preparation of optically pure aminophenylthio- and aminoaphthalenylthio-propanoic acids F. HOFFMANN-LA ROCHE AG (CH) 1989-11-29 — — EP disclosed
EP-0320817-A1 2,3-Dihydro-2-phenyl-5-amino-alkyl-naphtho[2,1-b][1,4]thiazepinone derivatives F. HOFFMANN-LA ROCHE AG (CH) 1989-06-21 — — EP disclosed
EP-0234561-A2 2,3-Dihydro-2-phenyl-5-aminoalkyl-naphtho [1,2-b]-1,4-thiazepin-4(5H)-one derivatives F. HOFFMANN-LA ROCHE AG (CH) 1987-09-02 — — EP disclosed
US-4652561-A HYPOTENSIVE AGENTS, ANTIISCHEMIC AGENTS HOFFMANN-LA ROCHE INC. (US) 1987-03-24 — — US disclosed
Send feedback